Arkolith/Insider Trading/ME/Form 4

Richards William G

Head of Therapeutics Discovery23andMe Holding Co. (ME) · full profile →Form 4 · filed Sep 19, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2023Grant(A)344K—$0555K
Sep 15, 2023Grant(A)116K—$0671K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 15, 2023Grant(A)166K—$0166K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-049917) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML